Kanagawa, Japan

Takashi Sawada

This inventor holds 43 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Input Devices. Top assignees: Sony Corporation, Kyowa Hakko Kirin Co., Limited, Canon Kabushiki Kaisha. Active years: 1989-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Sawada. Retrieved from https://idiyas.com/inventor/takashi-sawada-t1dgn06z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 43 

% Patents Active = 62.8


 

Average Co-Inventor Count = 2.9

ph-index = 12

Forward Citations = 470(Granted Patents)


Location History:

  • Yokohama, JP (2010 - 2012)
  • Sunto-gun, JP (2012)
  • Tokyo, JP (1989 - 2017)
  • Kanagawa, JP (1994 - 2017)
  • Shizuoka, JP (2015 - 2019)

Company Filing History:


Years Active: 1989-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Input Device
Touch-Sensitive Sheet
Image Forming Process
Therapeutic Agent
Electronic Apparatus
Recording Medium
Vibration Assembly
Heterocyclic Compound
Inkjet Recording
Microporous Body
Valve Assembly
Tape Cassette
43 patents (USPTO):Explore Patents

Title: Takashi Sawada: Innovator in Therapeutic Agents for Motor Disorders

Introduction

Takashi Sawada, an esteemed inventor based in Kanagawa, Japan, has made significant contributions to the field of medical innovation, particularly in the area of therapeutic agents for movement disorders. With an impressive portfolio of 42 patents, his work demonstrates a commitment to enhancing the quality of life for individuals afflicted by various neurological conditions.

Latest Patents

Among his notable recent inventions is a therapeutic agent designed for the treatment and prophylaxis of movement disorders such as extrapyramidal syndrome, bradykinesia, gait disturbance, dystonia, dyskinesia, and tardive dyskinesia. This innovative agent utilizes a thiazole derivative as an active ingredient, aiming to alleviate side effects associated with L-DOPA and dopamine agonist therapy. His research in this area highlights the dynamic interplay between pharmacology and neurobiology, showcasing the potential for new treatment modalities in alleviating motor disorders.

Career Highlights

Throughout his career, Takashi Sawada has gained valuable experience working for prominent organizations, including Sony Corporation and Kyowa Hakko Kirin Co., Limited. His tenure at these companies has not only bolstered his expertise but has also facilitated the development and commercialization of his groundbreaking inventions.

Collaborations

In his pursuit of innovation, Takashi has collaborated with notable colleagues such as Shuichi Ota and Kouichiro Takashima. These partnerships underline the importance of teamwork in the realm of scientific research and patent development, enabling the synthesis of diverse ideas and techniques to address complex medical challenges.

Conclusion

Takashi Sawada exemplifies the spirit of innovation within the field of therapeutic agents for motor disorders. His extensive patent portfolio and collaborations with industry leaders mark him as a significant figure in medical research. As the world continues to evolve, the impact of his inventions promises to provide therapeutic advancements that will benefit countless individuals struggling with movement disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…